- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 1st, 2005
Quantum dots, nanosized fluorescent semiconductor particles, are fast becoming a versatile tool for tracking movements of individual molecules in living systems thanks to their brightness, multiple colors, size, resistance to photobleaching, and commercial availability. Two recent papers highlight additional applications that cancer biologists could find useful.
In a paper published in Nature Medicine, a collaborative team lead by Rakesh Jain, Ph.D, and Dai Fukumura, M.D., Ph.D., both at Harvard Medical School, and Moungi Bawendi, Ph.D., of the Massachusetts Institute of Technology (MIT), detail the use of quantum dots to differentiate tumor cells from perivascular cells and the surrounding matrix and to study various processes that occur during tumor development.
|Related News Press|
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016
Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016
Nanotechnology Treatment Found to Inhibit Mesothelioma Tumor Growth November 16th, 2016
Quantum obstacle course changes material from superconductor to insulator December 1st, 2016
Throwing new light on printed organic solar cells December 1st, 2016